LIVEventures

LIVEventures brings together a dynamic team of professionals with extensive backgrounds spanning pharmaceuticals, medical devices, and entrepreneurial ventures. Their collaborative expertise enables them to provide not just capital, but also strategic guidance to emerging healthcare innovators. The team's hands-on investment philosophy emphasizes active participation in portfolio companies, ensuring alignment between business objectives and investor outcomes through personalized mentorship and industry connections.

Specializing in early-stage healthcare investments, LIVEventures targets seed and pre-seed funding rounds where their expertise can have maximum impact. This strategic focus allows them to identify promising medical technologies before they reach broader market awareness. Their investment thesis centers on companies developing solutions with clear potential to address unmet patient needs, improve clinical outcomes, or enhance healthcare delivery systems through technological innovation.

The firm maintains a deliberate geographic concentration on Switzerland and neighboring European Union countries, leveraging their regional expertise and networks across these innovation-rich markets. This regional focus enables LIVEventures to maintain close relationships with academic institutions, research hospitals, and biotech clusters that serve as sources for breakthrough medical technologies. Their portfolio reflects a diverse range of healthcare subsectors including digital health platforms, diagnostic tools, therapeutic devices, and specialized medical services.

What distinguishes LIVEventures in the competitive investment landscape is their commitment to patient-centric innovations with transformative potential. Their investment decisions are guided by rigorous assessment of both clinical value and commercial viability, seeking technologies that can demonstrate meaningful improvements in patient care while offering sustainable business models. The team's combined experience navigating regulatory pathways, clinical validation processes, and healthcare reimbursement systems provides crucial support to early-stage companies facing the complex challenges of bringing medical innovations to market.